0001437749-17-017238.txt : 20171018 0001437749-17-017238.hdr.sgml : 20171018 20171018144657 ACCESSION NUMBER: 0001437749-17-017238 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171016 FILED AS OF DATE: 20171018 DATE AS OF CHANGE: 20171018 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arrow Alexander K. CENTRAL INDEX KEY: 0001497166 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51353 FILM NUMBER: 171142520 MAIL ADDRESS: STREET 1: PO BOX 3094 CITY: REDWOOD CITY STATE: CA ZIP: 94064 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Protagenic Therapeutics, Inc.\new CENTRAL INDEX KEY: 0001022899 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 061390025 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 149 FIFTH AVENUE STREET 2: SUITE 500 CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: (212) 994-8200 MAIL ADDRESS: STREET 1: 149 FIFTH AVENUE STREET 2: SUITE 500 CITY: NEW YORK STATE: NY ZIP: 10010 FORMER COMPANY: FORMER CONFORMED NAME: Atrinsic, Inc. DATE OF NAME CHANGE: 20090630 FORMER COMPANY: FORMER CONFORMED NAME: NEW MOTION, INC. DATE OF NAME CHANGE: 20070504 FORMER COMPANY: FORMER CONFORMED NAME: MPLC, Inc. DATE OF NAME CHANGE: 20050608 4 1 rdgdoc.xml FORM 4 X0306 4 2017-10-16 0001022899 Protagenic Therapeutics, Inc.\new PTIX 0001497166 Arrow Alexander K. 149 FIFTH AVENUE, SUITE 500 NEW YORK NY 10010 1 Chief Financial Officer Non-Qualified Stock Options (Right to Buy) 1.75 2017-10-16 4 A 0 75000 0 A 2027-10-16 Protagenic Therapeutics, Inc. Common Stock 75000 75000 D Vesting in equal installments over 36 months, full vesting upon change of control /s/ Alexander K. Arrow 2017-10-17